AZ/Merck & Co' s Lynparza Gets US Approval For Prostate Cancer

Days After Green Light For Clovis's Rival PARP

 
• By Kevin Grogan
  
targets
Lynparza now approved for four tumor types • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category